There is no one solution to the development of antibody drug conjugates and every target brings its own set of challenges to development.

This webinar will show how different conjugations technologies can be assessed side by side for efficacy allowing the ability to screen and rank multiple product candidates to optimise your ADC right from the beginning.

We will also look at what considerations you need to make during process development and manufacturing to ensure you get a homogeneous product.